Correlation Between Legend Biotech and CSL
Can any of the company-specific risk be diversified away by investing in both Legend Biotech and CSL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Legend Biotech and CSL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Legend Biotech Corp and CSL, you can compare the effects of market volatilities on Legend Biotech and CSL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Legend Biotech with a short position of CSL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Legend Biotech and CSL.
Diversification Opportunities for Legend Biotech and CSL
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Legend and CSL is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Legend Biotech Corp and CSL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSL and Legend Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Legend Biotech Corp are associated (or correlated) with CSL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSL has no effect on the direction of Legend Biotech i.e., Legend Biotech and CSL go up and down completely randomly.
Pair Corralation between Legend Biotech and CSL
Given the investment horizon of 90 days Legend Biotech Corp is expected to generate 2.2 times more return on investment than CSL. However, Legend Biotech is 2.2 times more volatile than CSL. It trades about 0.0 of its potential returns per unit of risk. CSL is currently generating about -0.01 per unit of risk. If you would invest 4,945 in Legend Biotech Corp on September 1, 2024 and sell it today you would lose (738.00) from holding Legend Biotech Corp or give up 14.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Legend Biotech Corp vs. CSL
Performance |
| Timeline |
| Legend Biotech Corp |
| CSL |
Legend Biotech and CSL Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Legend Biotech and CSL
The main advantage of trading using opposite Legend Biotech and CSL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Legend Biotech position performs unexpectedly, CSL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will offset losses from the drop in CSL's long position.| Legend Biotech vs. Vaxcyte | Legend Biotech vs. Apellis Pharmaceuticals | Legend Biotech vs. Travere Therapeutics | Legend Biotech vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |